Top compounds associated with response to RPEL1


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.039 0.3
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.035 0.3
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA staurosporine CTRPv2 pan-cancer AAC -0.091 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.046 0.3
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.036 0.3
mRNA Merck60 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.3
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.038 0.3
Download CSV